Yu Wen Liu
Directeur/Membre du Conseil chez HANGZHOU TIGERMED CONSULTING CO., LTD
Profil
Yu Wen Liu is currently the Director at Suzhou PANOMIX Biomedical Tech Co., Ltd.
and an Independent Non-Executive Director at Hangzhou Tigermed Consulting Co., Ltd.
Ms. Liu previously held positions as a Director at BrightGene Bio-Medical Technology Co., Ltd., Innovent Biologics, Inc., and MEDx Translational Medicine Co., Ltd.
Additionally, Ms. Liu served as an Independent Director at Adagene, Inc. from 2022 to 2023 and as an Executive Director at Suzhou Industrial Park Biotech Development Co. Ltd.
from 2010 to 2014.
Ms. Liu also worked as a Founding Partner at Bohe Angel Fund.
Ms. Liu received a graduate degree from Fudan University in 2007, BI Norwegian Business School in 2007, and China Pharmaceutical University in 1997.
Postes actifs de Yu Wen Liu
| Sociétés | Poste | Début |
|---|---|---|
| HANGZHOU TIGERMED CONSULTING CO., LTD | Directeur/Membre du Conseil | 21/03/2024 |
Suzhou PANOMIX Biomedical Tech Co., Ltd.
 Suzhou PANOMIX Biomedical Tech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Panomik Biomedical Technology Co. Ltd. provides metabolomics testing and analysis services. The company is located in China. | Directeur/Membre du Conseil | - |
Anciens postes connus de Yu Wen Liu
| Sociétés | Poste | Fin |
|---|---|---|
| ADAGENE INC. | Directeur/Membre du Conseil | 28/04/2023 |
| Bohe Angel Fund | Corporate Officer/Principal | - |
MEDx Translational Medicine Co., Ltd.
 MEDx Translational Medicine Co., Ltd. Medical DistributorsDistribution Services MEDx Translational Medicine Co., Ltd. is a leading Chinese innovative company in companion diagnostics and precision medicine in China. The company is based in Suzhou, China. MEDx collaborates with hundreds of world-renowned pharmaceutical companies and has been rewarded with many certifications, including China CNAS, ISO17025, and US CAP ISO 13485, among others. The company was founded in 2013 as Qiagen Translational Medicine Co., Ltd. With comprehensive technology platforms, high-quality systems, and strong IVD R&D experience, MEDx offers integrated solutions from biomarker discovery to patient stratification for drug clinical trials, IVD/CDX R&D, and commercialization. The company was founded in 2013 by Ya Fei Zhang, who has been the CEO since then. | Directeur/Membre du Conseil | - |
| BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. | Directeur/Membre du Conseil | - |
Suzhou Industrial Park Biotech Development Co. Ltd.
 Suzhou Industrial Park Biotech Development Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Industrial Park Biotech Development Co. Ltd. operates as a Chinese biotechnology company. The private company is located in China. | President | - |
Formation de Yu Wen Liu
| Fudan University | Graduate Degree |
| BI Norwegian Business School | Graduate Degree |
| China Pharmaceutical University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. | Health Technology |
| HANGZHOU TIGERMED CONSULTING CO., LTD | Commercial Services |
| INNOVENT BIOLOGICS, INC. | Health Technology |
| ADAGENE INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Suzhou Industrial Park Biotech Development Co. Ltd.
Suzhou Industrial Park Biotech Development Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Industrial Park Biotech Development Co. Ltd. operates as a Chinese biotechnology company. The private company is located in China. | Commercial Services |
MEDx Translational Medicine Co., Ltd.
MEDx Translational Medicine Co., Ltd. Medical DistributorsDistribution Services MEDx Translational Medicine Co., Ltd. is a leading Chinese innovative company in companion diagnostics and precision medicine in China. The company is based in Suzhou, China. MEDx collaborates with hundreds of world-renowned pharmaceutical companies and has been rewarded with many certifications, including China CNAS, ISO17025, and US CAP ISO 13485, among others. The company was founded in 2013 as Qiagen Translational Medicine Co., Ltd. With comprehensive technology platforms, high-quality systems, and strong IVD R&D experience, MEDx offers integrated solutions from biomarker discovery to patient stratification for drug clinical trials, IVD/CDX R&D, and commercialization. The company was founded in 2013 by Ya Fei Zhang, who has been the CEO since then. | Distribution Services |
| Bohe Angel Fund | Finance |
Suzhou PANOMIX Biomedical Tech Co., Ltd.
Suzhou PANOMIX Biomedical Tech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Panomik Biomedical Technology Co. Ltd. provides metabolomics testing and analysis services. The company is located in China. | Commercial Services |
